Using telemetry to automate the detection of emesis in the ferret: New vistas for delayed emesis assessment

Journal of Pharmacological and Toxicological Methods

Volumn 68, Issue 1, 2013, Pages 160-165

  Goineau, Sonia ^a   Rompion, Sonia ^a   Guillaume, Philippe ^a   Barrais, Laurence ^a   Castagné, Vincent ^a  

^a Porsolt S A S Z A de Glatigné   (France)

Author keywords

Automated detection; Chemotherapy; Cisplatin; Emesis; Ferret; Telemetry

Indexed keywords

CISPLATIN; CYTOTOXIC AGENT;

ABDOMINAL PRESSURE; ANIMAL EXPERIMENT; ARTICLE; AUTOMATION; COMPUTER PROGRAM; CONTROLLED STUDY; CORRELATION COEFFICIENT; FERRET; MALE; MEDICAL DEVICE; NONHUMAN; RETCHING; TELEMETRY; VALIDATION STUDY; VOMITING;

AUTOMATED DETECTION; CHEMOTHERAPY; CISPLATIN; EMESIS; FERRET; TELEMETRY;

ABDOMINAL CAVITY; ANIMALS; ANTINEOPLASTIC AGENTS; AUTOMATION; CISPLATIN; FERRETS; INJECTIONS, INTRAPERITONEAL; MALE; PRESSURE; REPRODUCIBILITY OF RESULTS; STATISTICS, NONPARAMETRIC; TELEMETRY; TIME FACTORS; VOMITING;

ANIMALIA; MUSTELA;

EID: 84880036600     PISSN: 10568719     EISSN: 1873488X     Source Type: Journal    
DOI: 10.1016/j.vascn.2013.03.010     Document Type: Article

References (22)

1. Andrews P.L., Horn C.C. Signals for nausea and emesis: Implications for models of upper gastrointestinal diseases. Autonomic Neuroscience 2006, 125:100-115.
2. Ballatori E., Roila F., Ruggeri B., Betti M., Sarti S., Soru G., et al. The impact of chemotherapy-induced nausea and vomiting on health-related quality of life. Supportive Care in Cancer 2007, 15:179-185.
3. Cepeda V., Fuertes M.A., Castilla J., Alonso C., Quevedo C., Pérez J.M. Biochemical mechanisms of cisplatin cytotoxicity. Anti-Cancer Agents in Medicinal Chemistry 2007, 7:3-18.
4. Chu K.M., Ngan M.P., Wai M.K., Yeung C.K., Andrews P.L., Percie du Sert N., et al. Olvanil, a non-pungent vanilloid enhances the gastrointestinal toxicity of cisplatin in the ferret. Toxicology Letters 2010, 192:402-407.
5. Fiore J.J., Gralla R.J. Pharmacologic treatment of chemotherapy-induced nausea and vomiting. Cancer Investigation 1984, 2:351-361.
6. Florczyk A.P., Schurig J.E., Bradner W.T. Cisplatin-induced emesis in the ferret: A new animal model. Cancer Treatment Reports 1982, 66:187-189.
7. Hesketh P.J. Chemotherapy-induced nausea and vomiting. The New England Journal of Medicine 2008, 358:2482-2494.
8. Huang D., Meyers K., Henry S., De la Torre F., Horn C.C. Computerized detection and analysis of cancer chemotherapy-induced emesis in a small animal model, musk shrew. Journal of Neuroscience Methods 2011, 197:249-258.
9. Kan K.K., Rudd J.A., Wai M.K. Differential action of anti-emetic drugs on defecation and emesis induced by prostaglandin E2 in the ferret. European Journal of Pharmacology 2006, 544:153-159.
10. Martin M. The severity and pattern of emesis following different cytotoxic agents. Oncology 1996, 53(Suppl. 1):26-31.
11. Milano S., Blower P., Romain D., Grélot L. The piglet as a suitable animal model for studying the delayed phase of cisplatin-induced emesis. Journal of Pharmacology and Experimental Therapeutics 1995, 274:951-961.
12. Percie du Sert N., Chu K.M., Wai M.K., Rudd J.A., Andrews P.L. Reduced normogastric electrical activity associated with emesis: A telemetric study in ferrets. World Journal of Gastroenterology 2009, 15:6034-6043.
13. Percie du Sert N., Holmes A.M., Wallis R., Andrews P.L. Predicting the emetic liability of novel chemical entities: A comparative study. British Journal of Pharmacology 2012, 165:1848-1867.
14. 3 receptor antagonists. Cancer Chemotherapy and Pharmacology 2011, 67:667-686.
15. Roila F., Donati D., Tamberi S., Margutti G. Delayed emesis: Incidence, pattern, prognostic factors and optimal treatment. Supportive Care in Cancer 2002, 10:88-95.
16. 1 receptor antagonism to prevent chemotherapy-induced nausea and vomiting. European Journal of Pharmacology 2012, 684:1-7.
17. Rudd J.A., Jordan C.C., Naylor R.J. The action of the NK1 tachykinin receptor antagonist, CP 99,994, in antagonizing the acute and delayed emesis induced by cisplatin in the ferret. British Journal of Pharmacology 1996, 119:931-936.
18. Rudd J.A., Naylor R.J. An interaction of ondansetron and dexamethasone antagonizing cisplatin-induced acute and delayed emesis in the ferret. British Journal of Pharmacology 1996, 118:209-214.
19. Schmoll H.J., Aapro M.S., Poli-Bigelli S., Kim H.K., Park K., Jordan K., et al. Comparison of an aprepitant regimen with a multiple-day ondansetron regimen, both with dexamethasone, for antiemetic efficacy in high-dose cisplatin treatment. Annals of Oncology 2006, 17:1000-1006.
20. Tattersall F.D., Rycroft W., Cumberbatch M., Mason G., Tye S., Williamson D.J., et al. The novel NK1 receptor antagonist MK-0869 (L-754,030) and its water soluble phosphoryl prodrug, L-758,298, inhibit acute and delayed cisplatin-induced emesis in ferrets. Neuropharmacology 2000, 39:652-663.
21. Tsukuda M., Ishitoya J., Mikami Y., Matsuda H., Katori H., Horiuchi C., et al. Antiemetic effects of granisetron and dexamethasone combination therapy during cisplatin-containing chemotherapy for head and neck cancer: Dexamethasone dosage verification trial. Internal Journal of Clinical Oncoly 2009, 14:337-343.
22. Watanabe Y., Okamoto M., Ishii T., Takatsuka S., Taniguchi H., Nagasaki M., et al. Long-lasting anti-emetic effect of T-2328, a novel NK(1) antagonist. Journal of Pharmacological Sciences 2008, 107:151-158.